News & Updates
Showing Infectious Diseases articles
Showing

Breakthrough infections with COVID-19 Delta variant linked to lower memory B cell response
The memory B cell response appears to be weaker in vaccinated individuals who develop breakthrough infections with the Delta variant of the coronavirus disease 2019 (COVID-19), according to a new Singapore study.

More than 1 in 4 young adults test seropositive for COVID-19
A recent study has shown that more than a quarter of young adults are seropositive for SARS-CoV-2, many of whom show single positivity with IgM. Such seropositivity was higher among those who had cases of the coronavirus disease 2019 (COVID-19) in the household and those who used public transport.

Do antihypertensive drugs raise odds of COVID-19 diagnosis, death?
Antihypertensive therapy (AHT) may be used safely during the COVID-19 pandemic, as no evidence suggest that it can increase the risk of SARS-CoV-2 infection or death, according to a UK study. In addition, most classes of antihypertensives are negatively associated with COVID-19 diagnosis.

COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease
Vaccines against SARS-CoV-2 has a safety profile that is similar in patients with inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD) and those with noninflammatory RMD (NI-RMD), according to a study. The vaccines are well tolerated with rare reports of I-RMD flare and serious adverse events.

5α-reductase inhibitors help reduce SARS-CoV-2 infection risk in men
Use of 5α-reductase inhibitors (5ARIs) appears to lower the risk of community-acquired infection with SARS-CoV-2 in men without prostate cancer, according to a study, noting that treatment with this drug class can help ease the burden of COVID-19.




